Glenmark gets $10 M from Forest
Facebook Twitter google+ RSS Feed

Glenmark gets $10 M from Forest

By siliconindia staff writer   |   Friday, 15 October 2004, 07:00 Hrs
Printer Print Email Email
MUMBAI: Glenmark Pharmaceuticals received $10 million from Forest Laboratories in the past quarter to September as an upfront drug licensing payment, the Bombay Stock Exchange said.

Glenmark said last month its Swiss subsidiary had given Forest the rights to develop and bring to market in North America a molecule for the treatment of chronic obstructive pulmonary disorder and asthma.

Glenmark was due to receive up to $190 million in upfront and milestone payments.

Glenmark's shares were up 0.91 per cent at Rs 311.30 at the Bombay Stock Exchange, whose benchmark index was up 0.40 per cent.




Experts on SiliconIndia
Santhosh  K
Sr. Soft. Engg.
Oracle India
Nehal Vyas
Sr. Team Lead
Cyberoam Tech.
Rani Malli
Sr. Director
Philips
Sr. Executive
ISB
Vijay Balkrishna Konduskar
Business Consultant
Imans Web Tech
Dr L P  Sharma
Technical Director
NIC
Reena Khanna
Founder
Solitaireworld
Dellas  Asse
sys-network admin
Computer Station
Write your comment now
Submit Reset
SPOTLIGHT